Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 50 entries
View as:

Kinetics of Circulating Tumor DNA in Lymphoma Treated by Immuno-chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06141772 Org: User:
Start: 11/15/23 End: 05/15/25 Due: 05/15/26

Tolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02095743 Org: User:
Start: 04/30/14 End: 03/31/19 Due: 03/31/20

Evaluation of Vascular Toxicity of Immune Checkpoint Inhibitors in Patients Head and Neck or Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05655663 Org: User:
Start: 12/20/22 End: 12/20/25 Due: 12/20/26

Dynamics of 18-FDG Uptake in Stage III/IV Non Small Cell Lung Cancer During First Line Pembrolizumab Treatment

Phase: N/A Priority: Normal
NCT ID: NCT03832348 Org: User:
Start: 06/17/19 End: 12/17/23 Due: 12/17/24

Detection of Recurrent Mutations in Waldenström's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03952052 Org: User:
Start: 01/14/19 End: 01/31/22 Due: 01/31/23

Circulating Tumor DNA Sequencing in Patients With Peripheral T-cell Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT06089941 Org: User:
Start: 11/02/23 End: 11/02/26 Due: 11/02/27

Efficacy of COVID-19 Vaccination in Patientstreated With Anti-CD20 for Follicular Lymphoma or Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04918940 Org: User:
Start: 05/21/21 End: 06/27/22 Due: 06/27/23

Study of the Clearance of Minimal Residual Disease Measured At the End of First-line Treatment in Patients with Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06744075 Org: User:
Start: 12/20/24 End: 12/20/27 Due: 12/20/28

Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01576796 Org: User:
Start: 03/31/12 End: 06/30/17 Due: 06/30/18

Kinetic of Cytokines Decrease and Hodgkin Lymphoma Prognostic

Phase: N/A Priority: Normal
NCT ID: NCT01833884 Org: User:
Start: 04/30/10 End: 06/30/16 Due: 06/30/17

Optimised Early Management of Squamous Cell Carcinoma of the Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04528420 Org: User:
Start: 09/01/20 End: 06/01/25 Due: 06/01/26

Dynamic 68Ga-PSMA and 18F-FDG PET/CT Analysis Prior to 177Lu-PSMA

Phase: N/A Priority: Normal
NCT ID: NCT06450548 Org: User:
Start: 06/15/24 End: 06/30/27 Due: 06/30/28

Study of Interest of Personalized Radiotherapy Dose Redistribution in Patients With Stage III NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT02473133 Org: User:
Start: 07/31/15 End: 12/31/20 Due: 12/31/21

Interest of Trimodality PET-CT Choline MRI Before Radiotherapy in High Risk Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03734757 Org: User:
Start: 10/16/18 End: 12/31/20 Due: 12/31/21

Role of PET Scan in the Evaluation of Early Response to Maintenance Treatment in Advanced Non-small-cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02507518 Org: User:
Start: 12/31/13 End: 03/31/19 Due: 03/31/20

Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid

Phase: N/A Priority: Normal
NCT ID: NCT02617745 Org: User:
Start: 11/30/15 End: 12/31/24 Due: 12/31/25

Circulating Tumor DNA in Primary Mediastinal Large B-cell Lymphoma (PMBL)

Phase: N/A Priority: Normal
NCT ID: NCT04824950 Org: User:
Start: 03/22/21 End: 03/01/28 Due: 03/01/29

Feasibility of ORGAnoids in Routine Clinical Practice for Molecular Analysis of the GLIOvascular Niche in Patients With Primary Brain Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT07029100 Org: User:
Start: 07/01/25 End: 07/01/29 Due: 07/01/30

Predictive Value of FDG-TEP During Radiotherapy or Chemo-radiotherapy in Patients With NCSC on the One-year Survival

Phase: N/A Priority: Normal
NCT ID: NCT01261598 Org: User:
Start: 11/30/07 End: 12/31/13 Due: 12/31/14

Influence of Body Composition on Chemotherapy Outcomes in Localized Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05858398 Org: User:
Start: 05/30/23 End: 05/02/26 Due: 05/02/27

Detection and Prognostic Value of Recurrent XPO1 Mutations of Patients With Classical Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02815137 Org: User:
Start: 06/01/16 End: 06/30/20 Due: 06/30/21

Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT

Phase: N/A Priority: Normal
NCT ID: NCT01261585 Org: User:
Start: 12/31/08 End: 12/31/09 Due: 12/31/10

Study of Hypoxia Measured in F-Miso PET/Scan and MRI in Patients With Squamous Cells Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04031534 Org: User:
Start: 03/21/19 End: 03/31/22 Due: 03/31/23

Contribution of Residual Tumour DNA Testing on the Surgical Bed

Phase: N/A Priority: Normal
NCT ID: NCT05934929 Org: User:
Start: 08/01/23 End: 08/01/27 Due: 08/01/28

Study of the Angiogenesis by PET/CT in Patients With Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02490891 Org: User:
Start: 11/30/15 End: 05/31/20 Due: 05/31/21